احتلت مايو كلينك في مدينة روتشستر المرتبة الأولى في العالم مرة أخرى في قائمة نيوزويك لعام 2022 لـ "أفضل المستشفيات في العالم". هذا التصنيف تقديرٌ لعمل الموظفين في مايو كلينك.
Mayo Clinic en Rochester ocupó una vez más el primer lugar en el mundo en la lista de Newsweek sobre los «Mejores hospitales del mundo» en 2022. Esta clasificación es un tributo al trabajo realizado por el personal de todo Mayo Clinic.
A Mayo Clinic em Rochester foi classificada mais uma vez como nº 1 do mundo pela Newsweek na lista de 2022 dos “Melhores Hospitais do Mundo”. A classificação é uma homenagem ao trabalho da equipe de toda a Mayo Clinic.
Patients with impaired immunity have faced a difficult predicament during the pandemic. Their condition places them at risk of severe Covid-19 complications, but until now, no-one knew if they were at higher risk of adverse side-effects following vaccination against Covid-19. A new study trialed two mRNA vaccines in such patients and found that they are safe and well tolerated. The results will help immunocompromised patients in making an informed choice about vaccination.
In early 2021, researchers at Johns Hopkins Medicine and NORC at the University of Chicago showed that the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use successfully helped more than 400 U.S. hospitals ensure that patients only received antibiotics when needed, and then, only in the correct amounts and for the prescribed dosage period.
مدينة روتشستر، ولاية مينيسوتا — أكد قادة مجموعة أبحاث اللقاحات في مايو كلينك على الحاجة لإجراء دراسة طويلة الأمد على اللقاحات وآلياتها مع الوضع في الاعتبار سلامة المرضى في المستقبل.
Los directores del Grupo de Investigación sobre Vacunas en Mayo Clinic resaltan la necesidad de llevar a cabo estudios a largo plazo sobre las vacunas y sus mecanismos, con la mira puesta en la futura seguridad de los pacientes.
Os líderes do Grupo de Pesquisa em Vacinas da Mayo Clinic enfatizam a necessidade de aumentar os estudos de longo prazo das vacinas e seus mecanismos pensando na segurança futura dos pacientes.
In an opinion article appearing online Feb. 25 in the Journal of the American Medical Association, authors from University Hospitals and Case Western Reserve University write about the unexpected patient safety benefit resulting from remote monitoring of patients during the COVID-19 pandemic. One of the major lessons gained from the pandemic was that patients could now be monitored based on risks and needs rather than location in the hospital. Home monitoring and hospital at-home models offer the potential to transform care and potentially allow a substantial proportion of hospitalized patients to receive care from home.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current findings include targeted therapies for tumors with PIK3CA and FGFR mutations, a promising combination therapy for myelofibrosis, a new target to improve immunotherapy response in pancreatic cancer, a novel method of increasing chemoradiation sensitivity in glioblastoma, and greater understanding of the chronic lymphocytic leukemia immune microenvironment.
Achieving certification demonstrates to patients, employers and the healthcare team that a nurse’s knowledge reflects national standards and a strong personal commitment to patient safety. Since 1976, AACN Certification Corporation has collectively granted approximately 450,000 nursing certifications, with over 130,000 active certifications held.
Hackensack Meridian Hackensack University Medical Center earned its 29th Joint Commission (TJC) Disease Specific Care (DSC) certification, marking the most certifications of any hospital in the nation.
Stroke patients on long-term blood thinners who were given the clot-busting drug alteplase enjoyed better recoveries than those who did not receive the drug and had no increased risk of bleeding, a new study led by UTSW researchers shows. The results run counter to the common practice of withholding the clot-busting drug to these patients due to concerns over complications from bleeding.
Researchers at Children’s Hospital Los Angeles are taking a new and innovative approach to better understanding this important issue. Under a five-year grant from the National Heart, Lung, and Blood Institute, investigators led by Matthew Borzage, PhD, and his mentors, Bradley Peterson, MD, and John Wood, MD, PhD, are using novel MRI techniques to look inside the brain while a baby is under anesthesia.
Using a physician anesthesiologist-led Anesthesia Care Team model increases patient access to care, compared to nurse-administered sedation for gastrointestinal (GI) endoscopy procedures, according to research being presented at the American Society of Anesthesiologists’ ADVANCE 2022, the Anesthesiology Business Event.
Patients with COVID-19 in the intensive care unit (ICU) prescribed full-dose blood thinners are significantly more likely to experience heavy bleeding than patients prescribed a smaller yet equally effective dose, according to a recent University at Buffalo-led study.
Many people have questions about a range of new COVID-19 medications that recently became available to outpatients. Rita Shane, PharmD, vice president of Pharmacy Services and chief pharmacy officer at Cedars-Sinai, is available to comment on key points about these therapies.